ELUTIA INC.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 12510 PROSPERITY DRIVE, SILVER SPRING, MD, 20904
Mailing Address 12510 PROSPERITY DRIVE, SILVER SPRING, MD, 20904
Phone 240-247-1143
Fiscal Year End 1231
EIN 474790334
Financial Overview
FY2024
-$37.66M
Net Income
$19.28M
Cash & Equivalents
$-2.07
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 28, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
Material Events
8-K Strategy Change January 12, 2026
High Impact
- Reported preliminary net sales of $3.3 million for Q4 2025, a 16% increase year-over-year.
- Completely paid off a $26.9 million loan from SWK Holdings, significantly strengthening financial position and reducing interest expenses.
8-K Financial Distress January 2, 2026
High Impact
- ELUTIA INC. received a serious warning from Nasdaq for failing to meet two key listing rules: the Market Value Rule and the Minimum Bid Price Rule.
- The company's total market value has been below $35 million, and its stock price consistently below $1.00 per share.
Insider Trading
BUY 6 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.